The ROE as of July 2025 (TTM) for Nymox Pharmaceutical Corporation (NYMX) is 24.07%

According to Nymox Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current ROE is 24.07%. This represents a change of -60.84% compared to the average of 61.47% of the last 4 quarters.

Nymox Pharmaceutical Corporation (NYMX) Historical ROE (quarterly & annually)

How has NYMX ROE performed in the past?

The mean historical ROE of Nymox Pharmaceutical Corporation over the last ten years is -705.40%. The current 24.07% ROE has changed -103.41% with respect to the historical average. Over the past ten years (40 quarters), NYMX's ROE was at its highest in in the December 2022 quarter at 277.80%. The ROE was at its lowest in in the December 2021 quarter at -3385.54%.

Nymox Pharmaceutical Corporation (NYMX) ROE by Quarter and Year

Discovering the peaks and valleys of Nymox Pharmaceutical Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nymox Pharmaceutical Corporation (NYMX) Average ROE

How has NYMX ROE performed in the past?

The current ROE of Nymox Pharmaceutical Corporation (NYMX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nymox Pharmaceutical Corporation (NYMX) ROE vs. Peers

How is NYMX’s ROE compared to its peers?

Nymox Pharmaceutical Corporation’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-90.11%), greater than NervGen Pharma Corp. (-399.62%), greater than Acrivon Therapeutics, Inc. Common Stock (-44.66%), greater than Protagenic Therapeutics, Inc. (-860.52%), greater than Miromatrix Medical Inc. (-74.80%), greater than ZyVersa Therapeutics, Inc. (-111.93%), less than Navidea Biopharmaceuticals, Inc. (355.34%), greater than Lexaria Bioscience Corp. (-107.00%), greater than Oncorus, Inc. (-82.19%), greater than Centessa Pharmaceuticals plc (-56.89%), greater than Longboard Pharmaceuticals, Inc. (-33.03%), greater than Lumos Pharma, Inc. (-233.03%), less than ImmunoCellular Therapeutics, Ltd. (59.97%), greater than Cellectar Biosciences, Inc. (-195.98%), greater than Bolt Biotherapeutics, Inc. (-96.75%), greater than Evelo Biosciences, Inc. (-6232.76%), greater than Aptinyx Inc. (-96.38%), greater than Magenta Therapeutics, Inc. (-32.82%), greater than Aileron Therapeutics, Inc. (-112.37%), greater than ABVC BioPharma, Inc. (-31.13%),

Build a custom stock screener for Nymox Pharmaceutical Corporation (NYMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nymox Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nymox Pharmaceutical Corporation (NYMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nymox Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.